Phân Tích Mẫu Máu Khô cho Giám Sát Liều Thuốc Linezolid ở Bệnh Nhân Lao Kháng Thuốc Đa Phương
Tóm tắt
Từ khóa
#DBS #giám sát thuốc điều trị #linezolid #lao đa kháng thuốc #mẫu máu khô.Tài liệu tham khảo
AlffenaarJW. 2010. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Ther. Drug Monit. 32:97–101.
AntonySJ HarrellV ChristieJD AdamsHG RumleyRL. 1995. Clinical differences between pulmonary and extrapulmonary tuberculosis: a 5-year retrospective study. J. Natl. Med. Assoc. 87:187–192.
BolhuisMS PrangerAD AlffenaarJW. 2012. Linezolid: safety and efficacy monitoring. Eur. Respir. J. 39:1275–1276. (Letter.)
EdelbroekPM van der HeijdenJ StolkLM. 2009. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther. Drug Monit. 31:327–336.
EmmonsG RowlandM. 2010. Pharmacokinetic considerations as to when to use dried blood spot sampling. Bioanalysis 2:1791–1796.
FortunJ. 2005. Linezolid for the treatment of multidrug-resistant tuberculosis. J. Antimicrob. Chemother. 56:180–185.
GebhartBC BarkerBC MarkewitzBA. 2007. Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin. Pharmacotherapy 27:476–479.
HarmelinkIM AlffenaarJW WesselsAM GreijdanusB UgesDR. 2008. A rapid and simple liquid chromatography-tandem mass spectrometry method for the determination of linezolid in human serum. EJHP Science 14:3–7.
LiW TseFL. 2010. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 24:49–65.
PrammanananT ChaiprasertA LeechawengwongsM. 2009. In vitro activity of linezolid against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR)-TB isolates. Int. J. Antimicrob. Agents. 33:190–191.
SinglaR. 2012. Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India. Eur. Respir. J. 39:956–962.
SpoonerN LadR BarfieldM. 2009. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal. Chem. 81:1557–1563.
SpoonerN RamakrishnanY BarfieldM DewitO MillerS. 2010. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations. Bioanalysis 2:1515–1522.
U.S. Department of Health and Human Services Food and Drug Administration. 2001. Guidance for industry. Bioanalytical method validation. U.S. Department of Health and Human Services Food and Drug Administration Rockville MD. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
VinhDC RubinsteinE. 2009. Linezolid: a review of safety and tolerability. J. Infect. 59(Suppl 1):S59–S74.
VuDH KosterRA AlffenaarJW BrouwersJR UgesDR. 2011. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 879:1063–1070.
World Health Organization. 2010. Treatment of tuberculosis: guidelines 4th ed. World Health Organization Geneva Switzerland. http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf.
YewWW ChauCH WenKH. 2008. Linezolid in the treatment of ‘difficult’ multidrug-resistant tuberculosis. Int. J. Tuberc. Lung Dis. 12:345–346.